Healthtech soonicorn Practo has announced its first full year of profitability in FY2024–25 (FY25), marking a significant milestone for the company. Cofounder and CEO Shashank ND shared the update with optimism, stating, “FY25 marked a quiet, but powerful shift – not just a profitable quarter, but our first full year of profitability – with six straight quarters and counting.”
In its FY25 annual letter, Practo reported an operating EBITDA of INR 15 Cr on a revenue of INR 234 Cr, reversing an EBITDA loss of INR 17 Cr in the previous fiscal year, when revenue stood at INR 240 Cr. The company first turned EBITDA positive in the June quarter of FY24.
During the year under review, Practo recorded a Gross Merchandise Value (GMV) of INR 3,500 Cr, having served over 5 crore patients across 640 cities. It enabled connections with more than 5 lakh verified doctors through its platform.
The company also highlighted its efforts in quality assurance, claiming to have audited over 1,000 healthcare establishments and analyzed more than 4 crore clinical data points to offer healthcare insights throughout the year.
Founded in 2008 by Shashank ND and Abhinav Lal, Practo helps patients book doctor appointments, consult online, order medicines, and schedule diagnostic tests. On the provider side, it offers practice management software for doctors, clinics, and hospitals, including solutions for appointment scheduling and electronic health records.
The startup reported 180% year-on-year growth in its hospital network, now surpassing 1.5 lakh hospitals, and currently operates 40 co-branded dermatology clinics across India.
With profitability now in the books, Practo has renewed focus on preparing for an IPO—a move that was first hinted at in its FY23 annual report.
“This year, we began preparing to go public. But for us, this isn’t just a financial milestone – it’s a step towards building an institution that lasts. We’re investing in leadership, governance, and long-term systems,” the company said.
While no specific timeline or IPO size has been disclosed, Practo confirmed that groundwork for the public listing is underway.